slotkoers
Korea S.E.
00:00:00 26-06-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
7.450
KRW
|
+1,92%
|
|
-2,87%
|
-29,18%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
141.469
|
119.395
|
156.395
|
167.123
|
227.536
|
118.793
|
Bedrijfswaarde
1 |
170.700
|
246.923
|
269.921
|
290.383
|
409.242
|
361.257
|
K/w-verhouding
|
-36,2
x
|
-5,35
x
|
-8,15
x
|
-2,36
x
|
-2,11
x
|
-1,99
x
|
Dividendrendement
|
1,52%
|
0,9%
|
0,72%
|
0,68%
|
0,5%
|
0,95%
|
Marktkapitalisatie/omzet
|
3,01
x
|
0,41
x
|
0,26
x
|
0,28
x
|
0,34
x
|
0,19
x
|
Bedrijfswaarde/omzet
|
3,63
x
|
0,84
x
|
0,45
x
|
0,49
x
|
0,61
x
|
0,57
x
|
Bedrijfswaarde/EBITDA
|
64,1
x
|
-50,5
x
|
9,73
x
|
-6,97
x
|
-6,96
x
|
-8,68
x
|
Bedrijfswaarde/FCF
|
109
x
|
-5,18
x
|
24,8
x
|
3,08
x
|
-2,98
x
|
-8,78
x
|
FCF Yield
|
0,92%
|
-19,3%
|
4,04%
|
32,5%
|
-33,6%
|
-11,4%
|
Price to Book
|
0,82
x
|
0,87
x
|
1,27
x
|
3,13
x
|
19,3
x
|
3,05
x
|
Aantal aandelen (in duizenden)
|
11.296
|
11.294
|
11.292
|
11.292
|
11.292
|
11.292
|
Referentieprijs
2 |
12.524
|
10.571
|
13.850
|
14.800
|
20.150
|
10.520
|
Datum van publicatie
|
14/03/19
|
12/03/20
|
18/03/21
|
17/03/22
|
16/03/23
|
14/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
47.050
|
292.221
|
596.469
|
592.375
|
675.540
|
638.448
|
EBITDA
1 |
2.664
|
-4.888
|
27.752
|
-41.660
|
-58.832
|
-41.608
|
Bedrijfsresultaat (EBIT)
1 |
-267
|
-25.871
|
-10.493
|
-81.732
|
-98.263
|
-79.553
|
Operationele Marge
|
-0,57%
|
-8,85%
|
-1,76%
|
-13,8%
|
-14,55%
|
-12,46%
|
Resultaat voor belastingen (EBT)
1 |
-2.944
|
-47.273
|
-28.408
|
-176.529
|
-172.950
|
-132.077
|
Nettowinst (verlies)
1 |
-3.719
|
-22.459
|
-19.185
|
-70.891
|
-102.353
|
-59.587
|
Nettomarge
|
-7,91%
|
-7,69%
|
-3,22%
|
-11,97%
|
-15,15%
|
-9,33%
|
WPA
2 |
-345,7
|
-1.975
|
-1.699
|
-6.278
|
-9.555
|
-5.277
|
Free Cash Flow
1 |
1.566
|
-47.672
|
10.896
|
94.273
|
-137.411
|
-41.144
|
FCF-marge
|
3,33%
|
-16,31%
|
1,83%
|
15,91%
|
-20,34%
|
-6,44%
|
Kasstroomconversie (ebitda)
|
58,76%
|
-
|
39,26%
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
2 |
190,5
|
95,24
|
100,0
|
100,0
|
100,0
|
100,0
|
Datum van publicatie
|
14/03/19
|
12/03/20
|
18/03/21
|
17/03/22
|
16/03/23
|
14/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
29.230
|
127.528
|
113.526
|
123.260
|
181.706
|
242.464
|
Nettokaspositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
10,97
x
|
-26,09
x
|
4,091
x
|
-2,959
x
|
-3,089
x
|
-5,827
x
|
Free Cash Flow
1 |
1.566
|
-47.672
|
10.896
|
94.273
|
-137.411
|
-41.144
|
ROE (netto-inkomsten/eigen vermogen)
|
-2,26%
|
-16,4%
|
-9,65%
|
-50,2%
|
-93,7%
|
-58%
|
ROA (netto-inkomsten/totale activa)
|
-0,06%
|
-3,02%
|
-0,82%
|
-5,9%
|
-6,89%
|
-5,72%
|
Totale activa
1 |
6.018.391
|
743.883
|
2.354.033
|
1.201.658
|
1.486.043
|
1.042.383
|
Nettoactief per aandeel
2 |
15.221
|
12.183
|
10.867
|
4.723
|
1.046
|
3.450
|
Cashflow per aandeel
2 |
3.128
|
9.247
|
11.115
|
15.466
|
8.767
|
6.304
|
Capex
1 |
3.141
|
9.364
|
18.142
|
17.153
|
12.698
|
13.487
|
Capex/omzet
|
6,68%
|
3,2%
|
3,04%
|
2,9%
|
1,88%
|
2,11%
|
Datum van publicatie
|
14/03/19
|
12/03/20
|
18/03/21
|
17/03/22
|
16/03/23
|
14/03/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -29,18% | 60,44 mln. | | +54,61% | 811 mld. | | +43,96% | 640 mld. | | -6,33% | 353 mld. | | +20,62% | 333 mld. | | +10,44% | 302 mld. | | +17,96% | 246 mld. | | +2,62% | 225 mld. | | +12,68% | 218 mld. | | +8,61% | 168 mld. |
Farmaceutische producten - Andere
|